We are live on ! Find out more
PAHC icon

Phibro Animal Health

145 hedge funds and large institutions have $417M invested in Phibro Animal Health in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 15

2% more funds holding

Funds holding: 142145 (+3)

0.13% more ownership

Funds ownership: 100.38%100.51% (+0.13%)

5% less capital invested

Capital invested by funds: $440M → $417M (-$22.8M)

28% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 58

Holders
145
Holders Change
+3
Holders Change %
+2.11%
% of All Funds
2.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
42
Reduced
58
Closed
15
Calls
Puts
Net Calls
Net Calls Change

PAHC Hedge Fund Activity: Q4 2021 in Review

145 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2021, worth a combined $417M — down 5.2% from $440M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new PAHC positions and 15 closed out — a net gain of 3 holders — while 42 added to existing stakes and 58 trimmed.

The largest buyer was BlackRock, adding an estimated $3.87M. The largest seller was Wells Fargo, cutting an estimated $4.5M.

  • 145 institutional investors held Phibro Animal Health (PAHC) as of Q4 2021, up from 142 in Q3 2021.
  • Funds reported $417M of Phibro Animal Health stock for Q4 2021, down 5.2% quarter-over-quarter.
  • 18 funds opened new Phibro Animal Health positions in Q4 2021 and 15 closed out, a net change of +3 holders.
  • The largest Phibro Animal Health buyer in Q4 2021 was BlackRock, an estimated $3.87M added.
  • The largest Phibro Animal Health seller in Q4 2021 was Wells Fargo, an estimated $4.5M sold.

Based on aggregated 13F filings for Q4 2021.